Elizabeth E Reed Travere Therapeutics, Inc. (TVTX) insider trading activity

Elizabeth E Reed is Chief Legal Officer and GC of Travere Therapeutics, Inc.. Currently has a direct ownership of 89,878 shares of TVTX, which is worth approximately $2.18 Million. The most recent transaction as insider was on Jan 11, 2022, when has been sold 5,000 shares (Common Stock) at a price of $27.4 per share, resulting in proceeds of $137,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 89.9K

0.44% 3M change

14.3% 12M change

Total Value Held $2.18 Million

ELIZABETH E REED Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 11 2022	SELL Open market or private sale	$137,000 $27.4 p/Share	5,000 Reduced 11.75%	37,548 Common Stock
Jan 10 2022	BUY Grant, award, or other acquisition	-	5,000 Added 10.52%	42,548 Common Stock
Aug 17 2021	SELL Open market or private sale	$24,088 $17.12 p/Share	1,407 Reduced 3.61%	37,548 Common Stock
Aug 13 2021	BUY Grant, award, or other acquisition	-	4,500 Added 10.36%	38,955 Common Stock
May 12 2021	SELL Open market or private sale	$31,622 $19.46 p/Share	1,625 Reduced 4.5%	34,455 Common Stock
May 11 2021	SELL Open market or private sale	$31,102 $19.14 p/Share	1,625 Reduced 4.31%	36,080 Common Stock
Feb 08 2021	SELL Open market or private sale	$71,055 $31.58 p/Share	2,250 Reduced 5.63%	37,705 Common Stock
Feb 05 2021	SELL Open market or private sale	$70,672 $31.41 p/Share	2,250 Reduced 5.33%	39,955 Common Stock
Feb 03 2021	SELL Open market or private sale	$91,789 $28.91 p/Share	3,175 Reduced 7.77%	37,705 Common Stock
Feb 03 2021	BUY Grant, award, or other acquisition	-	4,500 Added 9.63%	42,205 Common Stock
Feb 02 2021	SELL Open market or private sale	$97,631 $30.75 p/Share	3,175 Reduced 7.21%	40,880 Common Stock
Jan 31 2021	BUY Grant, award, or other acquisition	-	5,000 Added 10.19%	44,055 Common Stock
Jan 21 2021	BUY Grant, award, or other acquisition	-	15,000 Added 27.75%	39,055 Common Stock
Jan 06 2021	SELL Open market or private sale	$18,583 $27.01 p/Share	688 Reduced 2.78%	24,055 Common Stock
Jan 05 2021	SELL Open market or private sale	$18,335 $26.65 p/Share	688 Reduced 2.71%	24,743 Common Stock
Nov 16 2020	SELL Open market or private sale	$59,950 $23.98 p/Share	2,500 Reduced 8.95%	25,431 Common Stock
Nov 13 2020	SELL Open market or private sale	$59,050 $23.62 p/Share	2,500 Reduced 8.22%	27,931 Common Stock
Nov 11 2020	BUY Grant, award, or other acquisition	-	5,000 Added 14.11%	30,431 Common Stock

EER

Elizabeth E Reed

Chief Legal Officer and GC

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TVTX shares.

Notify only if

Value

Insider Trading

Get notified when an Travere Therapeutics, Inc. insider buys or sells TVTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Travere Therapeutics, Inc.

Track Activities on TVTX

Account